Xenon Pharmaceuticals XENE Stock
Xenon Pharmaceuticals Price Chart
Xenon Pharmaceuticals XENE Financial and Trading Overview
| Xenon Pharmaceuticals stock price | 33.78 USD |
| Previous Close | 42.61 USD |
| Open | 42.54 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 40.98 - 42.75 USD |
| 52 Week Range | 28.79 - 43.75 USD |
| Volume | 625.04K USD |
| Avg. Volume | 395.9K USD |
| Market Cap | 2.67B USD |
| Beta (5Y Monthly) | 1.424295 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 52.31 USD |
XENE Valuation Measures
| Enterprise Value | 2.19B USD |
| Trailing P/E | N/A |
| Forward P/E | -13.134375 |
| PEG Ratio (5 yr expected) | -0.27 |
| Price/Sales (ttm) | 3999.2864 |
| Price/Book (mrq) | 3.8612769 |
| Enterprise Value/Revenue | 3282.895 |
| Enterprise Value/EBITDA | -13.773 |
Trading Information
Xenon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.424295 |
| 52-Week Change | 37.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 43.75 USD |
| 52 Week Low | 28.79 USD |
| 50-Day Moving Average | 39.82 USD |
| 200-Day Moving Average | 37.56 USD |
XENE Share Statistics
| Avg. Volume (3 month) | 395.9K USD |
| Avg. Daily Volume (10-Days) | 445.38K USD |
| Shares Outstanding | 63.56M |
| Float | 58.41M |
| Short Ratio | 7.84 |
| % Held by Insiders | 0.82% |
| % Held by Institutions | 99.23% |
| Shares Short | 2.92M |
| Short % of Float | 4.62% |
| Short % of Shares Outstanding | 4.59% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -24075.59% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.73% |
| Return on Equity (ttm) | -23.99% |
Income Statement
| Revenue (ttm) | 668K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -96333000 USD |
| EBITDA | -159223008 USD |
| Net Income Avi to Common (ttm) | -147430000 USD |
| Diluted EPS (ttm) | -2.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 527.04M USD |
| Total Cash Per Share (mrq) | 8.29 USD |
| Total Debt (mrq) | 11.63M USD |
| Total Debt/Equity (mrq) | 1.69 USD |
| Current Ratio (mrq) | 23.714 |
| Book Value Per Share (mrq) | 10.885 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -114413000 USD |
| Levered Free Cash Flow (ttm) | -66362624 USD |
Profile of Xenon Pharmaceuticals
| Country | United States |
| State | BC |
| City | Burnaby |
| Address | 3650 Gilmore Way |
| ZIP | V5G 4W8 |
| Phone | 604 484 3300 |
| Website | https://www.xenon-pharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 203 |
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.
Q&A For Xenon Pharmaceuticals Stock
What is a current XENE stock price?
Xenon Pharmaceuticals XENE stock price today per share is 33.78 USD.
How to purchase Xenon Pharmaceuticals stock?
You can buy XENE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xenon Pharmaceuticals?
The stock symbol or ticker of Xenon Pharmaceuticals is XENE.
Which industry does the Xenon Pharmaceuticals company belong to?
The Xenon Pharmaceuticals industry is Biotechnology.
How many shares does Xenon Pharmaceuticals have in circulation?
The max supply of Xenon Pharmaceuticals shares is 76.54M.
What is Xenon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Xenon Pharmaceuticals PE Ratio is now.
What was Xenon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Xenon Pharmaceuticals EPS is -3.01 USD over the trailing 12 months.
Which sector does the Xenon Pharmaceuticals company belong to?
The Xenon Pharmaceuticals sector is Healthcare.
Xenon Pharmaceuticals XENE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19961.28 USD — |
-3.07
|
— — | 19666.65 USD — | 20320.18 USD — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| NASDAQ Biotechnology NBI | 3931.86 USD — |
-1.96
|
— — | 3898 USD — | 4000.18 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1727.53 USD — |
-1.77
|
— — | 1703.28 USD — | 1740.16 USD — | — - | — — |
- {{ link.label }} {{link}}